Regulacje i polityka gospodarcza · 11/10/2006

Public Teleconference Regarding Licensing and Collaborative Research Opportunities for: A Promising Treatment for Inflammatory Arthritis Targeting the Pre-ligand Assembly Domain (PLAD) of Tumor Necrosis Factor Receptors; Michael J. Lenardo et al. (NIAID)

The National Institute of Allergy and Infectious Diseases (NIAID) is hosting a public teleconference to discuss licensing and collaborative research opportunities for a promising treatment for inflammatory arthritis targeting the pre-ligand assembly domain (PLAD) of tumor necrosis factor receptors, led by Dr. Michael J. Lenardo. The conference aims to explore potential partnerships for this innovative treatment.